Latest Biotechnology, Pharmaceutical and Healthcare News from b3C NEWSWIRE

01:16 EDT 2nd April 2020 | BioPortfolio

Here are the most relevant search results for "b3C NEWSWIRE" found in our extensive news archives from over 250 global news sources.

More Information about b3C NEWSWIRE on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about b3C NEWSWIRE for you to read. Along with our medical data and news we also list b3C NEWSWIRE Clinical Trials, which are updated daily. BioPortfolio also has a large database of b3C NEWSWIRE Companies for you to search.

Showing News Articles 1–25 of 375 from b3C NEWSWIRE

Friday 27th March 2020

Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer

Pioneering new technologies for resetting the immune system, developing novel, first-in-class therapies for inflammatory and immunological diseases LONDON, UK, March 27, 2020 / B3C newswire / -- Immune Regulation Ltd, a clinical stage biotech company, today announces the appointment of Jonathan Rigby as CEO and a member of the Board of Directors. Based in the U.S., Jonathan is an experienced CEO ...

Wednesday 25th March 2020

Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials

SHANGHAI, China, March 25, 2020 / B3C newswire / -- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, has supported CanSino Biologics Inc. (“CanSinoBIO”) and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences (“Institute of Bioengineering”) in China in their development of the fir...

evitria Crosses 100-Citation Threshold

SCHLIEREN, Switzerland, March 25, 2020 / B3C newswire / -- evitria AG, a global antibody expression service provider, announces that it has crossed the 100-citation threshold on Google Scholars. Researchers around the globe use evitria's services to advance their research and publish their ground-breaking findings in renowned scientific journals. Among many other highly cited publications, one re...

Tuesday 24th March 2020

Immunogenesis Contracts ProBioGen for Development and Large-Scale Manufacturing Services

BERLIN, Germany and HOUSTON, USA, March 24, 2020 / B3C newswire / -- ProBioGen AG today announced that Immunogenesis, Inc., a spin-off of the MD Anderson Cancer Center, University of Texas, has signed a Service Agreement for Cell Line Development, Process Development and GMP

Monday 23rd March 2020

Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy

    OXFORD, UK, March 23, 2020 / B3C newswire / -- Vaccitech Limited and the University of Oxford today announce initial efficacy and safety data for ADVANCE, a Phase 2a study testing VTP-800, an immunotherapeutic product candidate in patients with metastatic castration resistant prostate cancer (mCRPC). The study demonstrated

Tuesday 17th March 2020

Haselmeier Receives Medical Device Master File Number for D-Flex Product Platform

STUTTGART, Germany, March 17, 2020 / B3C newswire / -- Haselmeier officially announces that it has received Master File Number MAF3202 from the Food and Drug Administration (FDA) of the United States for its D-Flex product platform, a new generation of injection pen systems for subcutaneous self-administration. A device master file provides regulatory authorities with proprietary data about a mat...

Friday 13th March 2020

Deuterium Depletion as a Possible New Strategy to Combat SARS-CoV-2

BUDAPEST, Hungary, March 13, 2020 / B3C newswire / -- Since December 2019, the world is facing the new coronavirus challenge, and measures have been taken against the outbreak. The continuously increasing number of prevalence of coronavirus infected patients and the death cases clearly show, that there is no therapy against coronaviruses yet. Considering all available data on the effect of deuter...

Thursday 12th March 2020

Toxys Raises €2 Million Financing for Global Expansion of its Unique Animal-Free Chemical Safety Tests

LEIDEN, The Netherlands, March 12, 2020 / B3C newswire / -- Toxys is an innovative Dutch biotech company that develops unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. Today, Toxys announces a €2 million funding round from KIKK Capital, InnovationQuarter, Zeeland Investment fund, Toxys management and Rabobank. This investment is be...

Tuesday 10th March 2020

Paradigm Shift in Angiography: Kinepict Medical Imaging Technology (KMIT) Receives US FDA 510(K) Clearance

BUDAPEST, Hungary, March 10, 2020 / B3C newswire / -- Kinepict Health Ltd. today announced that it has received US FDA 510(k) clearance for its Kinepict Medical Imaging Tool (KMIT) software, which uses the company’s proprietary, ground-breaking Digital Variance Angiography (DVA). Kinepict’s DVA technology revolutionizes the calculation of X-ray angiography images, innovating a field in which ...

Monday 9th March 2020

Sartorius Launches BIOSTAT STR® Generation 3 with BIOBRAIN - Making Biopharmaceutical Development and Production Faster, Simpler and Safer

Rapid process development and seamless scalability from ambr® to BIOSTAT STR® BioPAT® Toolbox—integrated single-use sensors for monitoring and control of key process parameters BIOBRAIN automation platform for flexible configuration, rapid upgrades and simple plant integration Process intensification with automated feed and bleed and integrated cell retention functionality Connection to Ume...

Tuesday 3rd March 2020

MIMETAS to Launch Assay Ready Product Line for Organ-on-a-Chip

Innovative in-vitro models ready-to-use for safety, ADME, and toxicology studies in drug development and food & nutrition research. LEIDEN, the Netherlands, March 03, 2020 / B3C newswire / -- MIMETAS announces the first product release of her Assay Ready product line: OrganoPlate® Caco-2. The product consists of 38 intestinal tubules that are grown under flow conditions against an extracellu...

Monday 2nd March 2020

Completion of Study Enrolment of Implandata’s Extraocular Eye Pressure Sensor for Continual Glaucoma Monitoring

HANNOVER, Germany, March 02, 2020 / B3C newswire / -- Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced that study enrolment of its international ARGOS-SC01 clinical study was completed with the inclusion of the 24th study patient. This first-in-human clinical study is conducted to validate the suprachoroidally placed EYEMATE-SC sensor implant for contin...

Tuesday 25th February 2020

Securecell Partners with Alit Life Science, Biofors Global Inc. and Danyel Biotech as Marketing & Sales Partners in China, South Korea and Israel

Securecell expands its market activities in Asia and Israel by cooperating with Shanghai based Alit Life Science, South Korea based Biofors Global and Rehovot based Danyel Biotech as partners for marketing and sales activities in China, Korea and Israel. URDORF (ZURICH), Switzerland, February 25, 2020 / B3C newswire / -- Securecell is proud to announce the partnership with

ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services

    BERLIN, Germany and SCHLIEREN, Switzerland, February 25, 2020 / B3C newswire / -- ProBioGen AG today announced that ImmunOs Therapeutics AG has signed a Manufacturing Services Agreement for their novel platform of multitasking

Wolfgang Kintzel to Become Cellbox Solutions’ CEO

KIEL, Germany, February 25, 2020 / B3C newswire / -- Cellbox Solutions today announces the expansion of its Board of Directors and the appointment of a new CEO - Wolfgang Kintzel will start as Chief Executive Officer effective March 1, 2020. The founder Prof. Kathrin Adlkofer will support the board in the function as COO. Wolfgang Kintzel has an extensive background in extracting full business po...

Monday 24th February 2020

Shuwen Biotech to Offer Breakthrough Preeclampsia Detection Device Globally through Collaboration with PerkinElmer

DEQING, China , February 24, 2020 / B3C newswire / -- Shuwen Biotech Co. Ltd., a China-based leader in innovative diagnostics announced  that PerkinElmer, Inc. will distribute Shuwen’s breakthrough diagnostic test for preeclampsia in over 100 countries around the globe, accounting for over 120 million pregnancies annually. According to the WHO, almost 80,000 women die and half a million pr...

Sartorius Introduces BioPAT® Spectro to Enable Raman Spectroscopy Capability and QbD with its ambr® and BIOSTAT STR® Platforms

Robust Raman model building in ambr® systems Raman model transfer from 15mL to 2000L single-use scale Qualified, ready-to-use, single-use spectroscopy port for BIOSTAT STR® bioreactors GOETTINGEN, Germany, February 24, 2020 / B3C newswire / -- Sartorius, a leading international partner of the biopharmaceutical industry today introduced BioPAT® Spectro, a Quality by Design (QbD) tool for use ...

Tuesday 18th February 2020

Good Laboratory Practices Software Upgrade for Biotage® Extrahera™

UPPSALA, Sweden , February 18, 2020 / B3C newswire / -- Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) is pleased to announce the launch of a Good Laboratory Practices (GLP) software upgrade for Biotage® Extrahera™, their flagship automated sample preparation instrument for Supported Liquid Extraction (SLE), Solid Phase Extraction (SPE), Phospholipid Depletion (PLD) and Protein Precipit...

Tuesday 11th February 2020

BD Completes Clinical Trial for BD Libertas™ Wearable Injector

GOTHENBURG, Sweden, February 11, 2020 / B3C newswire / -- BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the completion of a 50-subject human clinical trial with the BD Libertas™ Wearable Injector. The award-winning injector* is a subcutaneous drug delivery system, currently in development, that is designed to require no

Monday 3rd February 2020

RauCon Pharma Partnering Conferences Limit Attendance For More Value

HEIDELBERG, Germany, February 03, 2020 / B3C newswire / -- RauCon has now introduced limits to the number of participants of its euroPLX and asiaPLX Pharma Partnering Conferences in order to increase their value for the individual participant. The question whether or not expectations on a partnering event can be satisfied is largely determined by mathematics. One limiting factor is the dispo...

Tuesday 28th January 2020

SAGA Diagnostics Extends its Collaboration with Servier to Use Ultrasensitive SAGAsafe® Technology in Cancer Clinical Trials

LUND, Sweden, January 28, 2020 / B3C newswire / -- SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, today announces it has entered service agreements with the international pharmaceutical company Servier, based in Paris, France. “These deals exemplify the increased demand we are e...

Monday 27th January 2020

Bionetix, ProQinase, and MercachemSyncom Announce a Joint Research Project from Target Identification to Clinical Study

        SUWON, Korea, FREIBURG, Germany and NIJMEGEN–GRONINGEN, the Netherlands, January 27, 2020 / B3C newswire / --

Noscendo Expands Proprietary Diagnostic Platform DISQVER to Include Microbial Resistances in Partnership with University Hospital Bonn

Partnership plans molecular biological characterisation of up to 8000 clinically relevant isolates of pathogens resistant to multiple antibiotics using the latest sequencing technology. DUISBURG, Germany, January 27, 2020 / B3C newswire / -- Noscendo GmbH and the University Hospital Bonn (UKB) today announced the successful signing of a cooperative agreeme

Thursday 23rd January 2020

WISE Completes Enrolment in Pivotal Clinical Study of Novel Neuro-Electrodes for Brain Monitoring

Highly ergonomic and minimally invasive cortical strip electrodes on track for commercialization in 2020 MILAN, Italy, January 23, 2020 / B3C newswire / -- WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, has completed enrolment in the pivotal clinical study of its first product, the WISE Cortical S...

Tuesday 21st January 2020

Toxys Strengthens Leadership Team with Appointment of CBO and COO Positions

LEIDEN, The Netherlands, January 21, 2020 / B3C newswire / -- Today, Toxys announces the appointment of a Chief Business Officer (CBO) and a Chief Operating Officer (COO). Toxys BV is a biotech company based in Leiden, The Netherlands, that provides innovative, high-fidelity in vitro toxicity screening solutions to identify carcinogenic and other hazardous properties of compounds for the pharmace...

Quick Search

News Quicklinks